Carlyle Group Inc.
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 3, 2024), Carlyle Group Inc. reported 32 stock positions worth $1.6 billion. Its top holding was Quidelortho (QDEL) at 37.7% of the portfolio, followed by Zoominfo Technologies (GTM, 26.5%) and Soleno Therapeutics (SLNO, 10.9%). Compared with Q4 2023, it opened 10 new positions, sold out of 3, added to 3 and reduced 2. The biggest buy was Soleno Therapeutics (SLNO, shares +42%) and the biggest sale Zoominfo Technologies (GTM, shares −26%).
- Most Recent 13F
- Q2 2026
- Location
- WASHINGTON, DC
- CIK
- 0001527166
- Portfolio Value
- $1.6B (Q1 2024)
- SEC Filing
- 0000898432-24-000359 ↗ filed May 3, 2024
Holdings Value
Holdings 32 stocks · $1.6B
| QDEL Quidelortho Corp. | 37.66% | 12,460,183 | $597.3M | No change |
| GTM Zoominfo Technologies Inc. | 26.52% | 26,244,474 | $420.7M | Reduce -25.5% |
| SLNO Soleno Therapeutics Inc. | 10.91% | 4,071,562 | $173.1M | Add +42.5% |
| VTRU Vitru Ltd. | 5.93% | 6,246,471 | $94.0M | No change |
| VRNA Verona Pharma Ltd. | 2.49% | 2,457,500 | $39.4M | No change |
| GETY Getty Images Holdings Inc. | 2.41% | 9,212,799 | $38.2M | Reduce -1.9% |
| PHAT Phathom Pharmaceuticals Inc. | 2.34% | 3,496,808 | $37.1M | No change |
| JSPR Jasper Therapeutics Inc. | 1.97% | 1,066,189 | $31.3M | New |
| HLVX Hillevax Inc. | 1.92% | 1,838,486 | $30.5M | No change |
| GDS GDS Holdings Ltd. - ADR filed as GDS HLDGS LTD | 1.71% | 4,072,624 | $27.1M | No change |
| SMHI Seacor Marine Holdings Inc. | 1.15% | 1,314,164 | $18.3M | No change |
| QTTB Q32 Bio Inc. | 1.14% | 1,102,741 | $18.1M | New |
| INVH Invitation Homes Inc. | 1.07% | 477,500 | $17.0M | No change |
| CUBE Cubesmart | 0.63% | 220,500 | $10.0M | No change |
| ACET Adicet Bio Inc. | 0.43% | 2,948,718 | $6.9M | Add +39.4% |
| DNUT Krispy Kreme Inc. | 0.33% | 340,748 | $5.2M | New |
| RENEO PHARMACEUTICALS INC | 0.28% | 2,698,957 | $4.5M | No change |
| EM Smart Share Global Ltd. - ADR | 0.20% | 4,810,209 | $3.2M | No change |
| EFTR Effector Therapeutics Inc. | 0.17% | 192,884 | $2.7M | New |
| SPWR Sunpower Inc. filed as COMPLETE SOLARIA INC | 0.17% | 4,936,483 | $2.7M | Add +79.8% |
| SPRB Spruce Biosciences Inc. | 0.14% | 2,896,518 | $2.3M | No change |
| NABL N-Able Inc. | 0.08% | 93,732 | $1.2M | New |
| SWI Solarwinds Corp. | 0.07% | 93,735 | $1.2M | New |
| AVGO Broadcom Inc. | 0.06% | 755 | $1.0M | New |
| NU Nu Holdings Ltd./Cayman Isl-A filed as NU HLDGS LTD | 0.05% | 72,341 | $863K | New |
| NUCANA PLC | 0.05% | 3,333,333 | $845K | No change |
| DASH DoorDash Inc. Class A | 0.04% | 4,156 | $572K | New |
| SYRE Spyre Therapeutics Inc. | 0.02% | 9,620 | $365K | No change |
| META DATA LIMITED | 0.02% | 314,400 | $241K | No change |
| CFLT Confluent Inc. Class A | 0.01% | 7,683 | $234K | New |
| XCUR Exicure Inc. | 0.01% | 281,636 | $161K | No change |
| MTEMQ Molecular Templates Inc. | 0.00% | 13,333 | $29K | No change |
Portfolio Sells Q4 2023 → Q1 2024
| GTM Zoominfo Technologies Inc. | Reduce -25.5% | 26.52% | −4.82 |
| VERA Vera Therapeutics Inc. | Sold out | 0.00% | −1.06 |
| JSPR Jasper Therapeutics Inc. | Sold out | 0.00% | −0.32 |
| EFFECTOR THERAPEUTICS INC | Sold out | 0.00% | −0.11 |
| GETY Getty Images Holdings Inc. | Reduce -1.9% | 2.41% | +0.04 |
Portfolio Buys Q4 2023 → Q1 2024
| SLNO Soleno Therapeutics Inc. | Add +42.5% | 10.91% | +5.38 |
| JSPR Jasper Therapeutics Inc. | New | 1.97% | +1.97 |
| QTTB Q32 Bio Inc. | New | 1.14% | +1.14 |
| DNUT Krispy Kreme Inc. | New | 0.33% | +0.33 |
| ACET Adicet Bio Inc. | Add +39.4% | 0.43% | +0.24 |
| EFTR Effector Therapeutics Inc. | New | 0.17% | +0.17 |
| NABL N-Able Inc. | New | 0.08% | +0.08 |
| SWI Solarwinds Corp. | New | 0.07% | +0.07 |
| AVGO Broadcom Inc. | New | 0.06% | +0.06 |
| NU Nu Holdings Ltd./Cayman Isl-A | New | 0.05% | +0.05 |
| DASH DoorDash Inc. Class A | New | 0.04% | +0.04 |
| CFLT Confluent Inc. Class A | New | 0.01% | +0.01 |
| SPWR Sunpower Inc. | Add +79.8% | 0.17% | −0.03 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 19 | $10.0B | MDLN, SARO, PHAT, INVH, PONY |
| Q1 2026 | 20 | $10.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q4 2025 | 20 | $13.6B | MDLN, SARO, PHAT, PONY, INVH |
| Q3 2025 | 17 | $4.3B | SARO, PONY, PHAT, SPRB, INVH |
| Q2 2025 | 20 | $5.0B | SARO, SLNO, PHAT, PONY, INVH |
| Q1 2025 | 23 | $3.8B | SARO, SLNO, WRD, PHAT, PONY |
| Q4 2024 | 27 | $4.1B | SARO, SLNO, WRD, PONY, PHAT |
| Q3 2024 | 26 | $954.2M | QDEL, SLNO, GTM, PHAT, QTTB |
| Q2 2024 | 31 | $1.1B | QDEL, GTM, SLNO, GDS, PHAT |
| Q1 2024 | 32 | $1.6B | QDEL, GTM, SLNO, VTRU, VRNA |